世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床試験イメージング市場レポート:2023-2033


Clinical Trial Imaging Market Report 2023-2033

レポート詳細 臨床試験イメージング市場レポート 2023-2033 : 本レポートは、業界とその基礎となるダイナミクスをよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものと... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
Visiongain
ヴィジョンゲイン社
2023年4月27日 GBP4,500
部署ライセンス
ライセンス・価格情報・注文方法はこちら
272 277 英語

※上記価格は部署ライセンス(Departmental licence)価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

レポート詳細

臨床試験イメージング市場レポート 2023-2033: 本レポートは、業界とその基礎となるダイナミクスをよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にも有用です。

より精密で個別化された治療に対する需要の増加、臨床試験数の増加などが市場成長を牽引
臨床試験イメージングには、特定の薬剤や治療の恩恵を受けられる特定の遺伝子や疾患サブタイプの特徴を持つ患者を検出することで、治療を個別化できる可能性があります。そうすることで、治療の効果を高め、有害な副作用の可能性を低減することができます。新薬や治療法の需要が高まる中、世界中で実施されている臨床試験の数は増加傾向にあります。臨床試験用画像は、研究者が実験的な薬物や治療法が身体に与える影響を視覚化し定量化することで、これらの試験において重要な役割を担っています。MRI、CTスキャン、PETスキャンなどの高度な医療画像技術は、臓器、組織、細胞の複雑な画像を提供し、病気の進行の特定とモニタリング、新しい治療法の安全性と有効性の評価を可能にします。

熟練したプロフェッショナルの不足
臨床試験イメージング市場にとって大きな制約となるのは、熟練した専門家の不足です。臨床試験イメージングを効率的に実施するには、放射線科医、画像診断士、データアナリストなど、医療画像技術の取り扱いの訓練を受け、データ分析と解釈の専門知識を持つ熟練した専門家が必要です。しかし、残念ながら、医療用画像の分野では熟練したプロフェッショナルが不足しており、企業が彼らを採用し、維持することは困難な状況です。この不足は、新興市場や核医学や分子イメージングなどの画像診断の専門分野でより顕著に見られます。

マーケットリサーチレポートを購入する前に、どのような質問をするべきか?
- 臨床試験イメージング市場はどのように進化しているのか?
- 臨床試験イメージング市場を牽引し、抑制しているものは何か?
- 各臨床試験イメージングサブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める収益はどの程度か?
- 2023年から2033年にかけて、各臨床試験イメージングサブマーケットの市場シェアはどのように推移するのか?
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か?
- 主要な臨床試験イメージング市場は、マクロ経済のダイナミクスに幅広く追随するのか、それとも個々の国内市場が他を凌駕するのか?
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か?
- 主要プレイヤーは誰で、予測期間中の見通しは?
- 2020年から2033年の間に、業界はどのように進化していくのか?現在および今後10年間に行われる臨床試験イメージングプロジェクトはどのような意味を持つのか?
- 臨床試験イメージング市場をさらに拡大するために、製品の商業化の必要性は高まっているのか?
- 臨床試験イメージング市場はどこに向かっているのか、そして市場の最前線に立つためにはどうすればよいのか?
- 新製品やサービスラインに対する最適な投資オプションは何か?
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望は何か?

このことが、現在、そして今後10年間の臨床試験用画像処理市場にどのような影響を与えるかを知る必要があります:
- 272ページにわたる本レポートでは、115の表と162のチャート/グラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野を取り上げており、今すぐその分野をターゲットにすることができます。
- 世界、地域、国の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、臨床試験イメージング市場が今後10年間にどのように発展するか、またCOVID-19の景気後退やバウンスの変動に合わせて、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。

2033年までの予測やその他の分析により、商業的な展望を明らかにする。
- 今回の調査では、2033年までの収益予測に加え、直近の実績、成長率、市場シェアも掲載しています。
- ビジネスの展望や展開など、独自の分析がご覧いただけます。
- 定性的分析(市場力学、促進要因、機会、阻害要因、課題など)、コスト構造、臨床試験イメージング価格上昇の影響、最近の動向をご覧いただけます。

本レポートでは、COVID-19が業界や貴社にどのような影響を与えるかについて、データ分析および貴重な知見を提供しています。COVID-19の4つの回収パターン、すなわち「V」「L」「W」「U」の回収パターンとその影響について考察しています。

報告書の対象セグメント

ソフトウェア・サービス
- ソフトウエア
- サービス

モダリティ
- コンピュータ断層撮影
- 磁気共鳴画像法
- 超音波診断装置
- 陽電子放射断層撮影
- X線
- 心エコー図

治療領域
- オンコロジー
- 感染症
- 神経内科
- 神経内科
- 内分泌学
- 免疫疾患

エンドユーザー
- 製薬会社
- バイオテクノロジー企業
- 医療機器メーカー
- 受託研究機関
- 学術・政府研究機関

世界市場全体およびセグメントの収益予測に加え、4地域および主要20カ国市場の収益予測も掲載しています:

北米
- アメリカ
- カナダ

欧州
- ドイツ
- スペイン
- イギリス
- フランス
- ロシア
- イタリア
- その他の欧州

アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ地域

MEA
- GCC諸国
- 南アフリカ
- その他のMEA

レポートには、臨床試験イメージング市場の主要企業のプロファイルと2023年から2033年まで、これらの企業の事業のこのセグメントに焦点を当てたいくつかの企業についても含まれています。

主要企業と市場成長の可能性
・ BioTelemetry, a Philips Company
・ Calyx
・ Clario
・ eClinical Solutions LLC
・ ICON plc
・ IXICO plc
・ Medical Metrics, Inc.
・ Medpace
・ Medrio, Inc.
・ Novitas Life Sciences
・ Parexel International Corporation
・ Perspectum
・ Radiant Sage LLC
・ Resonance Health Ltd
・ Signant Health

臨床試験イメージング市場の世界全体の収益、2023年から2033年までの金額ベースで、市場は2022年に1,370.7百万米ドルを突破すると、我々の仕事は計算されます。2033年まで収益が大きく伸びることが予測されます。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的な展望を発見し、あなたが一歩先を行くのを支援します。

臨床試験イメージング市場、2023年から2033年までのレポートはどのように役立つのでしょうか?
まとめると、270ページを超えるレポートでは、以下のような知識を得ることができます:

- 臨床試験イメージング市場、2023年から2033年までの収益予測 世界および地域レベルで、ソフトウェアとサービス、モダリティ、治療薬、エンドユーザー、企業規模をそれぞれ予測 - 業界の展望を発見し、投資と収益のための最も有利な場所を見つけることができます。

- 4つの地域と20の主要国市場の2033年までの収益予測 - 臨床試験イメージング市場、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAの2023年から2033年の市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなど著名な経済圏の市場も予測されています。

- 2023年から2033年までの臨床試験イメージング市場に関わる主要企業15社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望。

独自の予測による定量・定性分析をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスとして情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性は低くなります。私たちの仕事があなたの研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、臨床試験イメージング市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためです。データ、トレンド、予測を見つけることができます。



ページTOPに戻る


目次

目次

1 レポートの概要
1.1 研究の目的
1.2 臨床試験イメージング市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問事項
1.6 本レポートは誰向けか?
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 プライマリーリサーチ
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場促進要因
3.2.1.1 臨床試験数の増加、R&D投資の増加
3.2.1.2 より正確で個別化された治療・診断への需要の高まり
3.2.1.3 イメージングモダリティの技術的進歩
3.2.2 市場抑制要因
3.2.2.1 熟練した専門家の不足と高コスト
3.2.2.2 画像処理機器とサービスの高コスト
3.2.2.3 規制上の課題
3.2.3 市場機会
3.2.3.1 画像処理サービスのアウトソーシング
3.2.3.2 慢性疾患の有病率の増加
3.2.3.3 人工知能(AI)および機械学習(ML)技術の導入の増加
3.3 COVID-19の影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーのバーゲニングパワー
3.4.2 バイヤーのバーゲニングパワー
3.4.3 競合のライバル関係
3.4.4 代替品からの脅威
3.4.5 新規参入の脅威
3.5 PEST分析

4 臨床試験イメージング市場分析:ソフトウェア・サービス別
4.1 主要な調査結果
4.2 ソフトウェアおよびサービスセグメント 市場魅力度指数
4.3 臨床試験イメージング市場規模推定と予測:ソフトウェア・サービス別
4.4 サービス
4.4.1 2023-2033年の地域別市場規模(US$ Million)
4.4.2 2023年・2033年地域別市場シェア(%)
4.4.3 サービス、2023年~2033年(US$ Million)
4.5 ソフトウェア
4.5.1 地域別市場規模、2023年~2033年(US$ Million)
4.5.2 2023年・2033年地域別市場シェア(%)

5 臨床試験イメージング市場分析:モダリティ別
5.1 主要な調査結果
5.2 モダリティ別セグメント 市場魅力度指数
5.3 臨床試験イメージング モダリティ別市場規模推定と予測
5.4 コンピュータ断層撮影
5.4.1 2023〜2033年の地域別市場規模(US$ Million)
5.4.2 2023年・2033年地域別市場シェア(%)
5.5 磁気共鳴イメージング
5.5.1 2023年~2033年、地域別市場規模(US$ Million)
5.5.2 2023年・2033年地域別市場シェア(%)
5.6 超音波
5.6.1 2023年~2033年の地域別市場規模(US$ Million)
5.6.2 2023年・2033年地域別市場シェア(%)
5.7 ポジトロンエミッショントモグラフィー
5.7.1 2023年~2033年の地域別市場規模(US$ Million)
5.7.2 2023年・2033年地域別市場シェア(%)
5.8 X線
5.8.1 2023年~2033年の地域別市場規模(US$ Million)
5.8.2 2023年・2033年地域別市場シェア(%)
5.9 心エコー図
5.9.1 2023年~2033年、地域別市場規模(US$ Million)
5.9.2 2023年・2033年地域別市場シェア(%)

6 臨床試験イメージング市場の分析:治療領域別
6.1 主要な調査結果
6.2 治療分野別セグメント 市場魅力度指数
6.3 臨床試験イメージング市場:治療領域別市場規模の推定と予測
6.4 オンコロジー
6.4.1 2023〜2033年の地域別市場規模(US$ Million)
6.4.2 2023年・2033年地域別市場シェア(%)
6.5 感染症
6.5.1 2023-2033年地域別市場規模(US$ Million)
6.5.2 2023年・2033年地域別市場シェア(%)
6.6 神経内科
6.6.1 2023年~2033年の地域別市場規模(US$ Million)
6.6.2 2023年・2033年地域別市場シェア(%)
6.7 CVS
6.7.1 2023年~2033年の地域別市場規模(US$ Million)
6.7.2 2023年・2033年地域別市場シェア(%)
6.8 エンドクリノロジー
6.8.1 2023-2033年地域別市場規模(US$ Million)
6.8.2 2023年・2033年地域別市場シェア(%)
6.9 免疫学的疾患
6.9.1 2023-2033年、地域別市場規模(US$ Million)
6.9.2 2023年・2033年地域別市場シェア(%)

7 臨床試験イメージング市場分析:エンドユーザー別
7.1 主要な調査結果
7.2 エンドユーザー・セグメント 市場魅力度指数
7.3 臨床試験イメージング市場 エンドユーザー別市場規模推定と予測
7.4 製薬会社
7.4.1 地域別市場規模、2023年〜2033年(US$ Million)
7.4.2 2023年・2033年地域別市場シェア(%)
7.5 バイオテクノロジー企業
7.5.1 2023年~2033年、地域別市場規模(US$ Million)
7.5.2 2023年・2033年地域別市場シェア(%)
7.6 医療機器メーカー
7.6.1 2023年~2033年、地域別市場規模(US$ Million)
7.6.2 2023年・2033年地域別市場シェア(%)
7.7 受託研究機関
7.7.1 2023年~2033年の地域別市場規模(US$ Million)
7.7.2 2023年・2033年地域別市場シェア(%)
7.8 学術機関および政府系研究機関
7.8.1 2023年~2033年の地域別市場規模(US$ Million)
7.8.2 地域別市場シェア、2023年・2033年(%)

8 臨床試験イメージング市場分析:地域別
8.1 主要な調査結果
8.2 地域別市場規模の推計と予測

9 北米の臨床試験イメージング市場分析
9.1 主要な調査結果
9.2 北米の臨床試験イメージング市場魅力度指数
9.3 北米の臨床試験イメージング国別市場、2023年、2028年、2033年(US$ Million)
9.4 北米の臨床試験イメージング市場規模推定と予測:国別
9.5 北米の臨床試験イメージング市場規模推定と予測:ソフトウェア・サービス別
9.6 北米の臨床試験イメージング市場規模推定と予測:モダリティ別
9.7 北米の臨床試験イメージング市場規模推定と予測:治療領域別
9.8 北米の臨床試験イメージング市場規模推定と予測:エンドユーザー別
9.9 米国臨床試験イメージング市場分析
9.10 カナダ臨床試験イメージング市場分析

10 欧州の臨床試験イメージング市場分析
10.1 主要な調査結果
10.2 欧州臨床試験イメージング市場魅力度指数
10.3 欧州臨床試験イメージング国別市場、2023年、2028年、2033年(US$ Million)
10.4 欧州臨床試験イメージング市場規模推定と予測:国別
10.5 欧州臨床試験イメージング市場規模推定と予測:ソフトウェア・サービス別
10.6 欧州臨床試験イメージング市場規模推定と予測:モダリティ別
10.7 欧州臨床試験イメージング市場規模推定と予測:治療領域別
10.8 欧州臨床試験イメージング市場規模推定と予測:エンドユーザー別
10.9 ドイツ臨床試験イメージング市場分析
10.10 フランス 臨床試験イメージング市場分析
10.11 イギリス 臨床試験イメージング市場の分析
10.12 イタリア臨床試験イメージング市場の分析
10.13 スペイン臨床試験イメージング市場の分析
10.14 ロシアの臨床試験イメージング市場の分析
10.15 その他の欧州の臨床試験イメージング市場の分析

11 アジア太平洋地域の臨床試験イメージング市場の分析
11.1 主要な調査結果
11.2 アジア太平洋地域の臨床試験イメージング市場魅力度指数
11.3 アジア太平洋地域の臨床試験イメージング市場の国別推移(2023年、2028年&2033年)(US$ Million)
11.4 アジア太平洋地域の臨床試験イメージング市場規模推移の国別推計と予測
11.5 アジア太平洋地域の臨床試験イメージング市場:ソフトウェア・サービス別の市場規模予測・予想
11.6 アジア太平洋地域の臨床試験用イメージングの市場規模推定と予測:モダリティ別
11.7 アジア太平洋地域の臨床試験用画像診断の市場規模予測・治療領域別予測
11.8 アジア太平洋地域の臨床試験用画像診断の市場規模予測・見通し:エンドユーザー別
11.9 中国 臨床試験用画像診断の市場分析
11.10 日本 臨床試験イメージング市場分析
11.11 インドの臨床試験用画像診断の市場分析
11.12 オーストラリアの臨床試験イメージング市場の分析
11.13 韓国臨床試験イメージング市場の分析
11.14 その他のアジア太平洋地域の臨床試験イメージング市場の分析

11 アジア太平洋地域の臨床試験イメージング市場の分析
11.1 主要な調査結果
11.2 アジア太平洋地域の臨床試験イメージング市場魅力度指数
11.3 アジア太平洋地域の臨床試験イメージング市場(国別、2023年、2028年、2033年)(US$ Million)
11.4 アジア太平洋地域の臨床試験イメージング市場規模国別推定と予測
11.5 アジア太平洋地域の臨床試験イメージング市場規模推定と予測:ソフトウェア・サービス別
11.6 アジア太平洋地域の臨床試験イメージング市場規模推定と予測:モダリティ別
11.7 アジア太平洋地域の臨床試験イメージング市場規模推定と予測:治療領域別
11.8 アジア太平洋地域の臨床試験イメージング市場規模推定と予測:エンドユーザー別
11.9 中国 臨床試験イメージング市場分析
11.10 日本の臨床試験イメージング市場の分析
11.11 インド臨床試験イメージング市場の分析
11.12 オーストラリア臨床試験イメージング市場の分析
11.13 韓国臨床試験イメージング市場の分析
11.14 その他のアジア太平洋地域の臨床試験イメージング市場の分析

12 ラテンアメリカの臨床試験イメージング市場分析
12.1 主要な調査結果
12.2 ラテンアメリカの臨床試験イメージング市場魅力度指数
12.3 ラテンアメリカの臨床試験イメージング国別市場、2023年、2028年、2033年(US$ Million)
12.4 ラテンアメリカの臨床試験イメージング市場規模推定と予測:国別
12.5 ラテンアメリカの臨床試験イメージング市場規模推定と予測:ソフトウェア・サービス別
12.6 ラテンアメリカの臨床試験イメージング市場規模推定と予測:モダリティ別
12.7 ラテンアメリカの臨床試験イメージング市場規模推定と予測:治療領域別
12.8 ラテンアメリカの臨床試験イメージング市場規模推定と予測:エンドユーザー別
12.9 ブラジル臨床試験イメージング市場分析
12.10 メキシコ臨床試験イメージング市場分析
12.11 ラテンアメリカのその他の地域の臨床試験イメージング市場の分析

13 MEA臨床試験イメージング市場分析
13.1 主要な調査結果
13.2 MEAの臨床試験イメージング市場魅力度指数
13.3 MEAの臨床試験イメージング国別市場、2023年、2028年、2033年(US$ Million)
13.4 MEAの臨床試験イメージング市場規模推定と予測国別
13.5 MEAの臨床試験イメージング市場規模推定と予測:ソフトウェア・サービス別
13.6 MEAの臨床試験イメージング市場規模推定と予測:モダリティ別
13.7 MEAの臨床試験イメージング市場規模推定と予測:治療領域別
13.8 MEAの臨床試験イメージング市場規模推定と予測:エンドユーザー別
13.9 GCC臨床試験イメージング市場分析
13.10 南アフリカの臨床試験イメージング市場の分析
13.11 MEAのその他の地域の臨床試験イメージング市場の分析

14 会社概要
14.1 競争環境、2022年
14.2 戦略的な展望
14.3 ICON plc
14.3.1 企業スナップショット
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 収益、2018年~2022年
14.3.3.2 地域別市場シェア、2022年
14.3.4 製品ベンチマーキング
14.3.5 戦略的な展望
14.4 BioTelemetry, a Philips Company
14.4.1 カンパニー・スナップショット
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 売上高、2018年〜2022年
14.4.3.2 地域別市場シェア、2021年
14.4.3.3 R&D費、2017年~2021年
14.4.4 製品のベンチマーキング
14.4.5 戦略的な展望
14.5 Clario
14.5.1 企業スナップショット
14.5.2 会社概要
14.5.3 製品ベンチマーク
14.5.4 戦略的な展望
14.6 Navitas Life Sciences
14.6.1 企業スナップショット
14.6.2 会社概要
14.6.3 製品ベンチマーキング
14.6.4 戦略的な展望
14.7 Resonance Health Ltd
14.7.1 企業スナップショット
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 売上高、2018年〜2021年
14.7.3.2 地域別市場シェア、2021年
14.7.4 製品ベンチマーキング
14.8 Parexel International Corporation
14.8.1 企業スナップショット
14.8.2 会社概要
14.8.3 製品ベンチマーキング
14.8.4 戦略的展望
14.9 Medrio, Inc.
14.9.1 企業スナップショット
14.9.2 会社概要
14.9.3 ベンチマーキング製品
14.9.4 戦略的な展望
14.10 Signant Health
14.10.1 企業スナップショット
14.10.2 会社概要
14.10.3 製品のベンチマーキング
14.10.4 戦略的な展望
14.11 Perspectum
14.11.1 企業スナップショット
14.11.2 会社概要
14.11.3 製品ベンチマーク
14.11.4 戦略的な展望
14.12 Medical Metrics, Inc.
14.12.1 企業スナップショット
14.12.2 会社概要
14.12.3 ベンチマーキング製品
14.13 Calyx
14.13.1 カンパニースナップショット
14.13.2 会社概要
14.13.3 製品ベンチマーク
14.13.4 戦略的な展望
14.14 Radiant Sage LLC
14.14.1 企業スナップショット
14.14.2 会社概要
14.14.3 製品ベンチマーク
14.15 Medpace
14.15.1 企業スナップショット
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 収益、2018年〜2022年
14.15.3.2 地域別市場シェア、2021年
14.15.4 製品ベンチマーキング
14.16 IXICO plc
14.16.1 企業スナップショット
14.16.2 会社概要
14.16.3 財務分析
14.16.3.1 売上高、2018年〜2022年
14.16.3.2 地域別市場シェア、2021年
14.16.3.3 R&D費、2017年~2021年
14.16.4 製品のベンチマーキング
14.16.5 戦略的な展望

15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場関係者への提言

ページTOPに戻る



図表リスト

表の一覧
Table 1 Clinical Trial Imaging Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 1 Total Clinical Trials by Phase of Development
Table 2 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Global Clinical Trial Imaging Market Forecast by Services, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 9 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Computed Tomography Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 12 Magnetic Resonance Imaging Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 13 Ultrasound Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Positron Emission Tomography Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR %)
Table 15 X-ray Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Echocardiography Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 17 Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Mn,
AGR%, CAGR %)
Table 18 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 20 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 CVS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Endocrinology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Immunology Disorder Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Clinical Trial Imaging Market Forecast by End User, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 25 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 26 Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 27 Medical Device Manufacturer Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 28 Contract Research Organizations Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 29 Academic and Government Research Institutes Segment Market Forecast by Region,
2023-2033, (US$ Million, AGR%, CAGR%)
Table 30 Global Clinical Trial Imaging Market Forecast by Region 2023-2033, (US$ Mn, AGR%, CAGR%)
Table 31 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 32 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 33 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR %)
Table 35 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 U.S. Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Canada Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 38 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million,
AGR%, CAGR %)
Table 39 Europe Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 41 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 42 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033
(US$ Million, AGR%, CAGR%)
Table 43 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Russia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Clinical Trial Imaging Market Forecast by Modality 2023-2033(US$ Million,
AGR%, CAGR%)
Table 53 Asia Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 55 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Asia-Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Clinical Trial Imaging Market Forecast by Software & Serices, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 64 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-
2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 72 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area 2023-2033
(US$ Million, AGR%, CAGR%)
Table 73 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 Strategic Outlook
Table 78 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 ICON plc: Product Benchmarking
Table 80 ICON plc: Strategic Outlook
Table 81 BioTelemetry, A Philips Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BioTelemetry, A Philips Company: Product Benchmarking
Table 83 BioTelemetry, A Philips Company: Strategic Outlook
Table 84 Clario: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Clario: Product Benchmarking
Table 86 Clario: Strategic Outlook
Table 87 Navitas Life Sciences: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Navitas Life Sciences: Product Benchmarking
Table 89 Navitas Life Sciences: Strategic Outlook
Table 90 Resonance Health Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Resonance Health Ltd: Product Benchmarking
Table 92 Parexel International Corporation: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Parexel International Corporation.: Product Benchmarking
Table 94 Parexel International Corporation: Strategic Outlook
Table 95 Medrio, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Medrio, Inc.: Product Benchmarking
Table 97 Medrio, Inc.: Strategic Outlook
Table 98 Signant Health: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Signant Health: Product Benchmarking
Table 100 Signant Health: Strategic Outlook
Table 101 Perspectum: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Perspectum: Product Benchmarking
Table 103 Perspectum: Strategic Outlook
Table 104 Medical Metrics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Medical Metrics, Inc.: Product Benchmarking
Table 106 Calyx: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Calyx: Product Benchmarking
Table 108 Calyx: Strategic Outlook
Table 109 Radiant Sage LLC: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Radiant Sage LLC: Product Benchmarking
Table 111 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Medpace: Product Benchmarking
Table 113 IXICO plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 IXICO plc: Product Benchmarking
Table 115 IXICO plc: Strategic Outlook

図の一覧
Figure 1 Clinical Trial Imaging Market Segmentation
Figure 2 Clinical Trial Imaging Market by Software and Services: Market Attractiveness Index
Figure 3 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
Figure 4 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 5 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
Figure 6 Clinical Trial Imaging Market Attractiveness Index by Region
Figure 7 Clinical Trial Imaging Market: Market Dynamics
Figure 8 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Clinical Trial Imaging Market: Porter’s Five Forces Analysis
Figure 13 Clinical Trial Imaging Market: PEST Analysis
Figure 14 Clinical Trial Imaging Market Forecast by Software And Services: Market Attractiveness Index
Figure 15 Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 16 Clinical Trial Imaging Market Share Forecast by Software and Services, 2023, 2028, 2033 (%)
Figure 17 Services Market Forecast by Region, 2023 2033 (US$ Million)
Figure 18 Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Services Market Forecast by Region, 2023 2033 (US$ Million)
Figure 20 Clinical Trial Imaging Market Share Forecast by Services, 2023, 2028, 2033 (%)
Figure 21 Software Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Software Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
Figure 24 Clinical Trial Imaging Market Forecast By Modality, 2023-2033 (US$ Million)
Figure 25 Clinical Trial Imaging Market Share Forecast by Modality, 2023, 2028, 2033 (%)
Figure 26 Computed Tomography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Computed Tomography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Magnetic Resonance Imaging Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Magnetic Resonance Imaging Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Ultrasound Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Ultrasound Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Positron Emission Tomography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Positron Emission Tomography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 X-ray Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 X-ray Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Echocardiography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 37 Echocardiography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 39 Clinical Trial Imaging Market Forecast By Therapeutic Area, 2023-2033 (US$ Million)
Figure 40 Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 41 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 42 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million)
Figure 44 Infectious diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Neurology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 46 Neurology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 CVS Market Forecast by Region, 2023-2033 (US$ Million)
Figure 48 CVS Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Endocrinology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 50 Endocrinology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Immunological Disorder Market Forecast by Region, 2023-2033 (US$ Million)
Figure 52 Immunological Disorder Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
Figure 54 Clinical Trial Imaging Market Forecast By End Users, 2023-2033 (US$ Million)
Figure 55 Clinical Trial Imaging Market Share Forecast by End Users, 2023, 2028, 2033 (%)
Figure 56 Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 57 Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 59 Biotechnology Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Medical Device Manufacturer Market Forecast by Region, 2023-2033 (US$ Million)
Figure 61 Medical Device Manufacturer Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 Contract Research Organizations Market Forecast by Region, 2023-2033 (US$ Million)
Figure 63 Contract Research Organizations Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Academic and Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million)
Figure 65 Academic and Government Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Clinical Trial Imaging Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 67 Clinical Trial Imaging Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 68 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 69 North America Clinical Trial Imaging Market Attractiveness Index
Figure 70 North America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 71 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
Figure 72 North America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 North America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 74 North America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 75 North America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
Figure 76 North America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 77 North America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 78 North America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 79 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 80 North America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 81 U.S. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 Canada Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 Europe Clinical Trial Imaging Market Attractiveness Index
Figure 84 Europe Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 85 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 86 Europe Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Europe Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ Million)
Figure 88 Europe Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 89 Europe Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 90 Europe Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 91 Europe Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 92 Europe Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 93 Europe Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 94 Europe Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 95 Germany Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 97 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
Figure 103 Asia Pacific Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 104 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
Figure 105 Asia Pacific Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 Asia-Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 107 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 108 Asia-Pacific Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
Figure 109 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 110 Asia-Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 111 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 112 Asia-Pacific Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ million)
Figure 113 Asia-Pacific Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 114 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 118 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 119 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 120 Latin America Clinical Trial Imaging Market Attractiveness Index
Figure 121 Latin America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 122 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 123 Latin America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 124 Latin America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ million)
Figure 125 Latin America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 126 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 127 Latin America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 128 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 129 Latin America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 130 Latin America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 131 Latin America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 132 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 133 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 134 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA Clinical Trial Imaging Market Attractiveness Index
Figure 136 MEA Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 137 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 138 MEA Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 139 MEA Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ million)
Figure 140 MEA Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 141 MEA Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 142 MEA Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 143 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 144 MEA Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 145 MEA Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 146 MEA Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 147 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 148 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 150 Clinical Trial Imaging Market: Company Share/Ranking, 2022
Figure 151 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 152 ICON plc: Regional Market Shares, 2022
Figure 153 BioTelemetry, A Philips Company: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 154 BioTelemetry, A Philips Company: Regional Market Shares, 2022
Figure 155 BioTelemetry, A Philips Company: R&D Expense, 2018-2022 (US$ Million, AGR%)
Figure 156 Resonance Health Ltd: Revenue, 2018-2021 (US$ Million, AGR%)
Figure 157 Resonance Health Ltd: Regional Market Shares, 2021
Figure 158 Medpace: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 159 Medpace: Regional Market Shares, 2022
Figure 160 IXICO plc: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 161 IXICO plc: Regional Market Shares, 2022
Figure 162 IXICO plc: R&D Expense, 2018-2022 (US$ Million, AGR%)

 

ページTOPに戻る


 

Summary

Report Details

The Clinical Trial Imaging Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors Such As Increasing Demand for More Precise and Personalized Treatments and Growing Number of Clinical Trials Are Driving the Market Growth
Clinical trial imaging has the potential to personalize treatments by detecting patients who have specific genetic or disease subtype characteristics that would benefit from a specific drug or treatment. By doing so, the effectiveness of treatments can be enhanced and the possibility of harmful side effects can be reduced. With the increasing demand for novel and enhanced drugs and therapies, the number of clinical trials being conducted worldwide is on the rise. Clinical trial imaging plays a crucial role in these trials by allowing researchers to visualize and quantify the impact of experimental drugs and therapies on the body. Advanced medical imaging techniques like MRI, CT scans, and PET scans offer intricate images of organs, tissues, and cells, enabling identification and monitoring of disease progression, as well as evaluation of the safety and effectiveness of new treatments.

Shortage of Skilled Professional
A major limitation for the clinical trial imaging market is the scarcity of proficient experts. The proficient execution of clinical trial imaging demands skilled professionals such as radiologists, imaging technicians, and data analysts who are trained in the handling of medical imaging technology and possess expertise in data analysis and interpretation. Unfortunately, there is a lack of skilled professionals in the medical imaging field, making it difficult for companies to recruit and retain them. This shortage is more noticeable in emerging markets and specialized areas of imaging, such as nuclear medicine and molecular imaging.

What Questions Should You Ask before Buying a Market Research Report?
• How is the clinical trial imaging market evolving?
• What is driving and restraining the clinical trial imaging market?
• How will each clinical trial imaging submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trial imaging submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trial imaging markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2033? What are the implications of clinical trial imaging projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trial imaging market?
• Where is the clinical trial imaging market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial imaging market today, and over the next 10 years:
• Our 272-page report provides 115 tables and 162 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial imaging market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial imaging prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Software and Services
• Software
• Services

Modality
• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Positron Emission Tomography
• X-ray
• Echocardiography

Therapeutic Area
• Oncology
• Infectious Diseases
• Neurology
• CVS
• Endocrinology
• Immunological Disorder

End-users
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturer
• Contract Research Organisations
• Academic and Government Research Institutes

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• Spain
• United Kingdom
• France
• Russia
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC Countries
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Imaging Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• BioTelemetry, a Philips Company
• Calyx
• Clario
• eClinical Solutions LLC
• ICON plc
• IXICO plc
• Medical Metrics, Inc.
• Medpace
• Medrio, Inc.
• Novitas Life Sciences
• Parexel International Corporation
• Perspectum
• Radiant Sage LLC
• Resonance Health Ltd
• Signant Health

Overall world revenue for clinical trial imaging market, 2023 to 2033 in terms of value the market will surpass US$1,370.7 million in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the clinical trial imaging market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for clinical trial imaging market, 2023 to 2033 Market, with forecasts for software and services, modality, therapeutics, end users and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the clinical trial imaging Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the clinical trial imaging Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the clinical trial imaging market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.



ページTOPに戻る


Table of Contents

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Imaging Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
3.2.1.2 Increasing demand for more precise and personalized treatments and diagnosis
3.2.1.3 Technological advancements in imaging modalities
3.2.2 Market Restraining Factors
3.2.2.1 Shortage and high costs of skilled professional
3.2.2.2 High cost of imaging equipment and services
3.2.2.3 Regulatory Challenges
3.2.3 Market Opportunities
3.2.3.1 Outsourcing of imaging services
3.2.3.2 Growing prevalence of chronic diseases
3.2.3.3 Increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Clinical Trial Imaging Market Analysis by Software and Services
4.1 Key Findings
4.2 Software and Services Segment: Market Attractiveness Index
4.3 Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
4.4 Services
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Services, 2023-2033 (US$ Million)
4.5 Software
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Clinical Trial Imaging Market Analysis by Modality
5.1 Key Findings
5.2 Modality Segment: Market Attractiveness Index
5.3 Clinical Trial Imaging Market Size Estimation and Forecast by Modality
5.4 Computed Tomography
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Magnetic Resonance Imaging
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Ultrasound
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Positron Emission Tomography
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 X-ray
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Echocardiography
5.9.1 Market Size by Region, 2023-2033 (US$ Million)
5.9.2 Market Share by Region, 2023 & 2033 (%)

6 Clinical Trial Imaging Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Infectious diseases
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Neurology
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 CVS
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Endocrinology
6.8.1 Market Size by Region, 2023-2033 (US$ Million)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Immunological Disorder
6.9.1 Market Size by Region, 2023-2033 (US$ Million)
6.9.2 Market Share by Region, 2023 & 2033 (%)

7 Clinical Trial Imaging Market Analysis by End Users
7.1 Key Findings
7.2 End Users Segment: Market Attractiveness Index
7.3 Clinical Trial Imaging Market Size Estimation and Forecast by End Users
7.4 Pharmaceutical Companies
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Biotechnology Companies
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Medical Device Manufacturer
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Contract Research Organizations
7.7.1 Market Size by Region, 2023-2033 (US$ Million)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Academic and Government Research Institutes
7.8.1 Market Size by Region, 2023-2033 (US$ Million)
7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Clinical Trial Imaging Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Clinical Trial Imaging Market Analysis
9.1 Key Findings
9.2 North America Clinical Trial Imaging Market Attractiveness Index
9.3 North America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America Clinical Trial Imaging Market Size Estimation and Forecast by Country
9.5 North America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
9.6 North America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
9.7 North America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
9.8 North America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
9.9 U.S. Clinical Trial Imaging Market Analysis
9.10 Canada Clinical Trial Imaging Market Analysis

10 Europe Clinical Trial Imaging Market Analysis
10.1 Key Findings
10.2 Europe Clinical Trial Imaging Market Attractiveness Index
10.3 Europe Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Country
10.5 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
10.6 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Modality
10.7 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
10.8 Europe Clinical Trial Imaging Market Size Estimation and Forecast by End Users
10.9 Germany Clinical Trial Imaging Market Analysis
10.10 France Clinical Trial Imaging Market Analysis
10.11 U.K. Clinical Trial Imaging Market Analysis
10.12 Italy Clinical Trial Imaging Market Analysis
10.13 Spain Clinical Trial Imaging Market Analysis
10.14 Russia Clinical Trial Imaging Market Analysis
10.15 Rest of Europe Clinical Trial Imaging Market Analysis

11 Asia Pacific Clinical Trial Imaging Market Analysis
11.1 Key Findings
11.2 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
11.3 Asia Pacific Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Country
11.5 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
11.6 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Modality
11.7 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
11.8 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by End Users
11.9 China Clinical Trial Imaging Market Analysis
11.10 Japan Clinical Trial Imaging Market Analysis
11.11 India Clinical Trial Imaging Market Analysis
11.12 Australia Clinical Trial Imaging Market Analysis
11.13 South Korea clinical trial imaging Market Analysis
11.14 Rest of Asia Pacific Clinical Trial Imaging Market Analysis

12 Latin America Clinical Trial Imaging Market Analysis
12.1 Key Findings
12.2 Latin America Clinical Trial Imaging Market Attractiveness Index
12.3 Latin America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Country
12.5 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
12.6 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
12.7 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
12.8 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
12.9 Brazil Clinical Trial Imaging Market Analysis
12.10 Mexico Clinical Trial Imaging Market Analysis
12.11 Rest of Latin America Clinical Trial Imaging Market Analysis
13 MEA Clinical Trial Imaging Market Analysis
13.1 Key Findings
13.2 MEA Clinical Trial Imaging Market Attractiveness Index
13.3 MEA Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Country
13.5 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
13.6 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Modality
13.7 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
13.8 MEA Clinical Trial Imaging Market Size Estimation and Forecast by End Users
13.9 GCC Clinical Trial Imaging Market Analysis
13.10 South Africa Clinical Trial Imaging Market Analysis
13.11 Rest of MEA Clinical Trial Imaging Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Strategic Outlook
14.3 ICON plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Revenue, 2018-2022
14.3.3.2 Regional Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 BioTelemetry, a Philips Company
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Revenue, 2018-2022
14.4.3.2 Regional Market Shares, 2021
14.4.3.3 R&D Expense, 2017-2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Clario
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Strategic Outlook
14.6 Navitas Life Sciences
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Product Benchmarking
14.6.4 Strategic Outlook
14.7 Resonance Health Ltd
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Revenue, 2018-2021
14.7.3.2 Regional Market Shares, 2021
14.7.4 Product Benchmarking
14.8 Parexel International Corporation
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Medrio, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.9.4 Strategic Outlook
14.10 Signant Health
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 Perspectum
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.11.4 Strategic Outlook
14.12 Medical Metrics, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 Calyx
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Radiant Sage LLC
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Medpace
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Revenue, 2018-2022
14.15.3.2 Regional Market Shares, 2021
14.15.4 Product Benchmarking
14.16 IXICO plc
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Revenue, 2018-2022
14.16.3.2 Regional Market Shares, 2021
14.16.3.3 R&D Expense, 2017-2021
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 Clinical Trial Imaging Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 1 Total Clinical Trials by Phase of Development
Table 2 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Global Clinical Trial Imaging Market Forecast by Services, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 9 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Computed Tomography Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 12 Magnetic Resonance Imaging Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 13 Ultrasound Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Positron Emission Tomography Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR %)
Table 15 X-ray Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Echocardiography Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 17 Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Mn,
AGR%, CAGR %)
Table 18 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 20 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 CVS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Endocrinology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Immunology Disorder Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Clinical Trial Imaging Market Forecast by End User, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 25 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 26 Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 27 Medical Device Manufacturer Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 28 Contract Research Organizations Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 29 Academic and Government Research Institutes Segment Market Forecast by Region,
2023-2033, (US$ Million, AGR%, CAGR%)
Table 30 Global Clinical Trial Imaging Market Forecast by Region 2023-2033, (US$ Mn, AGR%, CAGR%)
Table 31 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 32 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 33 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR %)
Table 35 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 U.S. Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Canada Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 38 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million,
AGR%, CAGR %)
Table 39 Europe Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 41 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 42 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033
(US$ Million, AGR%, CAGR%)
Table 43 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Russia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Clinical Trial Imaging Market Forecast by Modality 2023-2033(US$ Million,
AGR%, CAGR%)
Table 53 Asia Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 55 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Asia-Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Clinical Trial Imaging Market Forecast by Software & Serices, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 64 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-
2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 72 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area 2023-2033
(US$ Million, AGR%, CAGR%)
Table 73 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 Strategic Outlook
Table 78 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 ICON plc: Product Benchmarking
Table 80 ICON plc: Strategic Outlook
Table 81 BioTelemetry, A Philips Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BioTelemetry, A Philips Company: Product Benchmarking
Table 83 BioTelemetry, A Philips Company: Strategic Outlook
Table 84 Clario: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Clario: Product Benchmarking
Table 86 Clario: Strategic Outlook
Table 87 Navitas Life Sciences: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Navitas Life Sciences: Product Benchmarking
Table 89 Navitas Life Sciences: Strategic Outlook
Table 90 Resonance Health Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Resonance Health Ltd: Product Benchmarking
Table 92 Parexel International Corporation: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Parexel International Corporation.: Product Benchmarking
Table 94 Parexel International Corporation: Strategic Outlook
Table 95 Medrio, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Medrio, Inc.: Product Benchmarking
Table 97 Medrio, Inc.: Strategic Outlook
Table 98 Signant Health: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Signant Health: Product Benchmarking
Table 100 Signant Health: Strategic Outlook
Table 101 Perspectum: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Perspectum: Product Benchmarking
Table 103 Perspectum: Strategic Outlook
Table 104 Medical Metrics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Medical Metrics, Inc.: Product Benchmarking
Table 106 Calyx: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Calyx: Product Benchmarking
Table 108 Calyx: Strategic Outlook
Table 109 Radiant Sage LLC: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Radiant Sage LLC: Product Benchmarking
Table 111 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Medpace: Product Benchmarking
Table 113 IXICO plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 IXICO plc: Product Benchmarking
Table 115 IXICO plc: Strategic Outlook

List of Figures
Figure 1 Clinical Trial Imaging Market Segmentation
Figure 2 Clinical Trial Imaging Market by Software and Services: Market Attractiveness Index
Figure 3 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
Figure 4 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 5 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
Figure 6 Clinical Trial Imaging Market Attractiveness Index by Region
Figure 7 Clinical Trial Imaging Market: Market Dynamics
Figure 8 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Clinical Trial Imaging Market: Porter’s Five Forces Analysis
Figure 13 Clinical Trial Imaging Market: PEST Analysis
Figure 14 Clinical Trial Imaging Market Forecast by Software And Services: Market Attractiveness Index
Figure 15 Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 16 Clinical Trial Imaging Market Share Forecast by Software and Services, 2023, 2028, 2033 (%)
Figure 17 Services Market Forecast by Region, 2023 2033 (US$ Million)
Figure 18 Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Services Market Forecast by Region, 2023 2033 (US$ Million)
Figure 20 Clinical Trial Imaging Market Share Forecast by Services, 2023, 2028, 2033 (%)
Figure 21 Software Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Software Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
Figure 24 Clinical Trial Imaging Market Forecast By Modality, 2023-2033 (US$ Million)
Figure 25 Clinical Trial Imaging Market Share Forecast by Modality, 2023, 2028, 2033 (%)
Figure 26 Computed Tomography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Computed Tomography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Magnetic Resonance Imaging Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Magnetic Resonance Imaging Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Ultrasound Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Ultrasound Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Positron Emission Tomography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Positron Emission Tomography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 X-ray Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 X-ray Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Echocardiography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 37 Echocardiography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 39 Clinical Trial Imaging Market Forecast By Therapeutic Area, 2023-2033 (US$ Million)
Figure 40 Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 41 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 42 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million)
Figure 44 Infectious diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Neurology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 46 Neurology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 CVS Market Forecast by Region, 2023-2033 (US$ Million)
Figure 48 CVS Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Endocrinology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 50 Endocrinology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Immunological Disorder Market Forecast by Region, 2023-2033 (US$ Million)
Figure 52 Immunological Disorder Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
Figure 54 Clinical Trial Imaging Market Forecast By End Users, 2023-2033 (US$ Million)
Figure 55 Clinical Trial Imaging Market Share Forecast by End Users, 2023, 2028, 2033 (%)
Figure 56 Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 57 Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 59 Biotechnology Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Medical Device Manufacturer Market Forecast by Region, 2023-2033 (US$ Million)
Figure 61 Medical Device Manufacturer Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 Contract Research Organizations Market Forecast by Region, 2023-2033 (US$ Million)
Figure 63 Contract Research Organizations Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Academic and Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million)
Figure 65 Academic and Government Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Clinical Trial Imaging Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 67 Clinical Trial Imaging Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 68 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 69 North America Clinical Trial Imaging Market Attractiveness Index
Figure 70 North America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 71 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
Figure 72 North America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 North America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 74 North America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 75 North America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
Figure 76 North America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 77 North America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 78 North America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 79 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 80 North America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 81 U.S. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 Canada Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 Europe Clinical Trial Imaging Market Attractiveness Index
Figure 84 Europe Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 85 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 86 Europe Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Europe Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ Million)
Figure 88 Europe Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 89 Europe Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 90 Europe Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 91 Europe Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 92 Europe Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 93 Europe Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 94 Europe Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 95 Germany Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 97 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
Figure 103 Asia Pacific Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 104 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
Figure 105 Asia Pacific Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 Asia-Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 107 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 108 Asia-Pacific Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
Figure 109 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 110 Asia-Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 111 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 112 Asia-Pacific Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ million)
Figure 113 Asia-Pacific Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 114 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 118 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 119 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 120 Latin America Clinical Trial Imaging Market Attractiveness Index
Figure 121 Latin America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 122 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 123 Latin America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 124 Latin America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ million)
Figure 125 Latin America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 126 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 127 Latin America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 128 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 129 Latin America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 130 Latin America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 131 Latin America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 132 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 133 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 134 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA Clinical Trial Imaging Market Attractiveness Index
Figure 136 MEA Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 137 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 138 MEA Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 139 MEA Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ million)
Figure 140 MEA Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 141 MEA Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 142 MEA Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 143 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 144 MEA Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 145 MEA Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 146 MEA Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 147 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 148 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 150 Clinical Trial Imaging Market: Company Share/Ranking, 2022
Figure 151 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 152 ICON plc: Regional Market Shares, 2022
Figure 153 BioTelemetry, A Philips Company: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 154 BioTelemetry, A Philips Company: Regional Market Shares, 2022
Figure 155 BioTelemetry, A Philips Company: R&D Expense, 2018-2022 (US$ Million, AGR%)
Figure 156 Resonance Health Ltd: Revenue, 2018-2021 (US$ Million, AGR%)
Figure 157 Resonance Health Ltd: Regional Market Shares, 2021
Figure 158 Medpace: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 159 Medpace: Regional Market Shares, 2022
Figure 160 IXICO plc: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 161 IXICO plc: Regional Market Shares, 2022
Figure 162 IXICO plc: R&D Expense, 2018-2022 (US$ Million, AGR%)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD(oncology)の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社(Visiongain)は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04 10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る